Clinical Trial Detail

NCT ID NCT03761069
Title Study of PTC299 in Relapsed/Refractory Acute Leukemias
Recruitment Recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors PTC Therapeutics
Indications

acute myeloid leukemia

Therapies

PTC299

Age Groups: adult senior

No variant requirements are available.